References
- Vizzini A, Ercole E. Paralepistopsis gen. nov. and Paralepista (Basidiomycota, Agaricales). Mycotaxon. 2012;120:253–267.
- Ichimura T. A new poisonous mushroom. Bot Gaz. 1918;60:109–111.
- Drenth JP, Michiels JJ. Erythromelalgia and erythermalgia: diagnostic differentiation. Int J Dermatol. 1994;33:393–397.
- Nakajima N, Ueda M, Higashi N, Katayama Y. Erythromelalgia associated with Clitocybe acromelalga intoxication. Clin Toxicol (Phila). 2013;51:451–454.
- Saviuc PF, Danel VC, Moreau PA, et al. Erythromelalgia and mushroom poisoning. J Toxicol Clin Toxicol. 2001;39:403–407.
- Bessard J, Saviuc P, Chane-Yene Y, Monnet S, Bessard G. Mass spectrometric determination of acromelic acid A from a new poisonous mushroom: Clitocybe amoenolens. J Chromatogr A. 2004;1005:99–107.
- Senthilkumaran S, Menezes RG, Jena NN, Thirumalaikolundusubramanian P. Nicotinic acid in erythromelalgia associated with Clitocybe acromelalga intoxication: theories and therapy. Clin Toxicol (Phila). 2013;51:814.
- Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med. 2005;33:427–336.
- Shinozaki H. Pharmacology of the glutamate receptor. Prog Neurobiol. 1988;30:399–435.
- Konno K. Toxic principles from the fungus Clitocybe acromelalga (Dokusasako). [in Japanese]. Nippon Nougeikagaku Kaishi. 1989;63:876–879.
- Nakajima N, Ueda M, Higashi N, Katayama Y. Therapeutic potential of nicotinic acid in erythromelalgia associated with Clitocybe acromelalga intoxication. Clin Toxicol (Phila). 2013;51:815.
- Fukuwatari T, Sugimoto E, Yokoyama K, Shibata K. Establishment of animal model for elucidating the mechanism of intoxication by the poisonous mushroom Clitocybe acromelalga. [in Japanese]. Shokuhin Eiseigaku Zasshi. 2001;42:185–189.
- Hathock JN. Vitamin and mineral safety, 3rd ed. Washington DC: Council for Responsible Nutrition, 2013. p. 73.
- Husted JW, Ring EJ, Hirsh LF. Intraarterial nitroprusside treatment for ergotism. AJR Am J Roentgenol. 1978;131:1090–1092.